Trial Profile
NORA TRIAL (oral Navelbine in adjuvant):multicenter,prospective,phase II, randomized clinical trial concerning about adjuvant chemotherapy with cisplatin and vinorelbine according to an advanced schedule in the lung cancer with small cells.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2012
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms NORA
- 26 Jul 2011 New trial record